AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Nov 16, 2021
33298_dirs_2021-11-16_25384175-3df8-4f9a-a805-2af0fedff4af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-11-15
Reporting Person: Galluppi Stefan (Director, Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Common Stock, par value $0.01 | P | 2097 | $4.55 | Acquired | 5893 | Direct |
| 2021-11-15 | Common Stock, par value $0.01 | P | 100 | $4.54 | Acquired | 5993 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.01 | 1649800 | Indirect |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17